時間 | 題目 | 演講者 |
12:30-13:00 | 註冊 | |
13:00-13:05 | 開幕致詞 | 彭慶添理事長 |
專題演講 IModerator:彭慶添理事長 | ||
13:05-13:45 | 1.How to talk to your patients about switching rFVIII? 2.Look ahead: Continuously improved outcome and patient compliance by switching to reliable and effective rFV | 翁德甫醫師 王建得醫師 |
POST-WFH 演講 | Moderator: 林東燦醫師 | |
13:45-14:10 | Rare bleeding disorder: state of art | 翁德甫醫師 |
14:10-14:35 | Hemophilia Outcome Measures | 王建得醫師 |
特別演講 | Moderator: 沈銘鏡教授 | |
14:35-15:05 | Novel Long-Acting Factor and Non-Factor Therapies for Hemophilia:Focusing on FVIII-Fc-VWF(Exten-A BIVV001)and SiRNA(Fitusiran) | 張家堯醫師 |
15:05-15:25 | Coffee break | |
專題演講II (Nuwiq) Moderator:邱世欣教授 | ||
15:25-16:05 | 1.Going further to meet clinical needs (New data with Nuwiq from clinical trials and real world experience 2.Taking Newig into the future –The development of a subcutaneous rFVIII | 翁德甫醫師 林佩瑾醫師 |
POST-WFH 演講 | Moderator:陳宇欽醫師 | |
16:05-16:25 | Gene therapy of hemophilia: the cure on the horizon | 周聖傑醫師 |
16:25-16:50 | Review of von-Willebrand disease | 林敬業醫師 |
16:50-17:00 | 閉幕致詞 | 沈銘鏡教授 |
大會主席:彭慶添理事長 *教育學分:中華民國血液病學會1.5分;台灣臨床病理檢驗醫學會5分,公務人員終身學習時數4小時。 台灣內科醫學會,台灣兒科醫學會,台灣醫事檢驗學會申請中